Article
BACE1 regulates sleep–wake cycle through both enzymatic and non–enzymatic actions
2025-04-19
Abstract excerpt
The β-secretase BACE1 has become a prime target in Alzheimer’s disease (AD) therapy, because it drives the production of pathogenic amyloid β peptides. However, clinical trials with BACE1-targeting drugs were halted due to adverse effects on cognitive performance. We propose here that cognitive impairment by BACE1 inhibitors may be a corollary of a higher function of BACE1 related to proper sleep regulation. To ad...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0f54afce-c233-5f3b-8c69-8f8099cb9753
- DOI
- 10.1101/2025.04.17.648898
